Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Using a two-part testing plan could help identify those with advanced liver fibrosis among people with type 2 diabetes.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
Hepatitis C is one of the leading causes for cirrhosis, cancer and liver transplants. Here is what you need to know...
The regulatory agency requested further data to show whether its benefits outweigh its risks.
While women have a lower risk for NAFLD, once present, the disease advanced more rapidly.
About a quarter of people taking a higher dose of Ocaliva saw an improvement in liver fibrosis.
The application is based on study results showing that up to 23% of treated patients saw an improvement in liver fibrosis.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
Study finds people who took daily aspirin had a lower risk of NASH and advanced liver scarring.
Those with greater fibrosis before treating hep C see the greatest benefit.
Among a large group treated with minimal or no liver fibrosis, liver-health problems were almost nonexistent up to three years later.
In a recent study, half of those cured of hepatitis C developed signs of non-alcoholic fatty liver disease (NAFLD).
If you’re a diehard coffee lover, here’s another reason to indulge.
People with below-normal thyroid function were at higher risk for liver fat accumulation and advanced liver fibrosis in a recent study.
Having a parent or sibling with NAFLD-related cirrhosis dramatically increases the risk.
The National Institute for Health and Care has recommended a less invasive option for testing fibrosis among people with liver inflammation.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.